全球肿瘤医生网提醒患者:国内细胞免疫治疗技术,包括cart细胞,树突细胞疫苗,NK细胞,TILs细胞,TCR t细胞治疗,癌症疫苗等技术均处于临床试验阶段,未获准在医院正式使用。国内患者可以参加正规临床试验,在医生的监管下使用,全球肿瘤医生网不推荐患者贸然尝试任何医疗机构和研发机构的收费治疗。
作者:Kathleen Doheny HealthDay记者星期一,2017年5月1日(HealthDay新闻) - 小剂量阿司匹林
aspirin: Regularly taking "baby" aspirin appears to protect women from the most common type of
breast cancer, new research suggests.
Use of low-dose aspirin at least three times a week was linked to a 20 percent risk reduction for cancers known as hormone-receptor positive,
HER2 negative -- the most common
breast cancer subtype, said study senior author Leslie Bernstein.
That's a "moderate" reduction in risk, said Bernstein, a professor at the City of Hope Cancer Center in Duarte, Calif. It's "maybe not as good as
exercise," she said, but she added that more people might adhere to an aspirin regimen than an
exercise routine.
However, the study doesn't establish a direct cause-and-effect relationship, and Bernstein said it's too early to recommend taking daily aspirin for breast-cancer risk reduction.
Many adults already take low-dose aspirin (81 milligrams) daily to lower their risk of
heart attack. This study -- led by Christina Clarke, who was with the Cancer Prevention Institute of California -- looked at the
medication use of women enrolled in the ongoing California Teachers Study. That trial, begun in 1995, recruited more than 133,000 active and retired women teachers, administrators and other public school professionals.
In 2005, more than 57,000 participants answered questions about their use of aspirin and other medications, family history of
cancer, use of
hormone therapy,
alcohol use, exercise, height and weight. By 2013, nearly 1,500 had developed invasive breast cancer.
Overall, regular baby aspirin use reduced the risk of
breast cancer 16 percent, the study says. But the more significant finding was the risk reduction for developing HR-positive/HER2-negative cancer, the researchers said.
The researchers found a protective link with use of low-dose aspirin, but not with regular-dose aspirin or other non-steroidal anti-inflammatory drugs such as ibuprofen or acetaminophen.
Why wouldn't higher-dose aspirin also be protective?
Regular-dose aspirin is more likely to be taken sporadically for
pain such as
headaches, the authors believe, while they think that women taking baby aspirin were doing so on a regular basis for
heart protection.
Continued
The researchers can only speculate as to why the baby aspirin appears to reduce risk of breast cancer.
"Aspirin not only reduces
inflammation, but it's a mild aromatase inhibitor," Bernstein said. Aromatase inhibitor drugs are used to treat hormone-receptor positive breast cancer in women past menopause, since they reduce the amount of
estrogen circulating in the blood, and the estrogen fuels the tumor.
Another researcher praised the study.
"This is really very exciting work," said Sushanta Banerjee, a professor of hematology and oncology at the University of Kansas Medical Center. In his research, confined to the lab and animals, "we found that aspirin has the capability to destroy the tumor-initiating cells that can lead to breast cancer."
In a study presented at a recent cancer meeting, his team reported that aspirin may prevent new blood vessels from forming and "feeding" the cancer.
Yet, he agreed it's too soon to suggest taking baby aspirin to reduce breast cancer risk.
If more study bears out the link between baby aspirin and
breast cancer prevention, Bernstein said low-dose aspirin may also help prevent recurrence.
The study was published online May 1 in the Breast Cancer Research journal. It was funded by the U.S. National Cancer Institute and the California Breast Cancer Research Fund.
https://www.webmd.com/breast-cancer/news/20170501/low-dose-aspirin-may-lower-risk-for-common-breast-cancer-by-20-percent
本网站新闻资讯、文章、研究数据、治疗案例均来自于国内外医学论文,所涉及到的新药、新技术有可能还处于临床研究阶段,患者不能作为治疗疾病的依据。癌症治疗目前尚无治愈手段,患者需要在医生的指导下,在医院接受正规治疗或参加新药新技术临床试验。
帮助广大患者在抗癌之路上少走/不走弯路
最终成功战胜病魔!
靶向治疗|最新资讯|临床试验|靶向药物|
基因检测|免疫治疗资讯|定期专家科普讲座